Cameco reports Q2 Thursday with consensus $600M revenue, $0.15 EPS; the realized uranium price under contracts will test whether the stock's mid-30s P/E is justified. Alpha Score 54 reflects the tension.
Cameco Corp. (CCJ) reports second-quarter results Thursday after the close, giving the market a read on whether earnings have caught up with a stock that has doubled since early 2023. The company's Alpha Score sits at 54 out of 100, a mixed reading from AlphaScala's internal model that blends valuation and fundamental metrics.
The world's largest publicly traded uranium producer has ridden the nuclear renaissance wave – utilities and governments signing long-term supply contracts, the restart of the McArthur River mine and Key Lake mill. The stock's forward price-to-earnings multiple in the mid-30s leaves little room for error. That run has already priced in much of the optimism around rising uranium prices and reactor restarts.
Consensus estimates call for roughly $600 million in revenue and adjusted earnings of about $0.15 a share. The analyst who wrote the article said the key metric is the realized uranium price under existing contracts, which lag the spot market. A beat on that number would support the bull case. A miss raises questions about contract timing and cost inflation at the mines.
The analyst said a strong number could push the stock toward its 52-week high near $55. A disappointment could test support around $45, a level the stock has bounced from twice. The earnings report after the close Thursday gives traders their next concrete date. For broader uranium market context, see AlphaScala's commodities analysis. More on CCJ stock page.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.